3,6'-丁纳糖调节了GALE介导的代谢重编程,以缓解喘性气道炎症
Haisong Jiang1, Ningpo Ding2, Zongqi Wang2
1Department of Anesthesiology, Yanbian University Medical College, Yanji 133002, PR China; Jilin Key Laboratory for Immune and Targeting Research on Common Allergic Diseases, Yanbian University, Yanji 133002, PR China.
International immunopharmacology
|September 4, 2025
概括
这项研究显示,UDP- 银-4- 酶 (GALE) 是喘的主要代谢驱动因素. 天然化合物3,6'-Disinapoyl Sucrose (DISS) 针对GALE减少呼吸道炎症和代谢功能障碍.
科学领域:
- 代谢学和系统生物学
- 呼吸系统疾病的分子机制
- 对喘的药理干预
背景情况:
- 喘包括慢性呼吸道炎症和新陈代谢失调,
- 糖解和氧化酸化 (OXPHOS) 的不平衡与喘的发病有关.
- 对于银河糖代谢至关重要的 UDP- 银河糖-4- 酶 (GALE) 尚未在喘中进行研究.
研究的目的:
- 使用生物信息学识别喘相关的代谢基因.
- 研究UDP-银糖-4-酶 (GALE) 在喘中的作用.
- 评估3. 6 - Disinapoyl Sucrose (DISS) 在调节GALE介导的代谢重编程方面的治疗潜力.
主要方法:
- 权重基因共同表达网络分析 (WGCNA) 和机器学习从支气管上皮数据集中确定了GALE.
- 虚拟查发现DISS是一种GALE抑制剂.
- 在体外 (BEAS-2B细胞) 和体内 (HDM诱导的喘小鼠模型) 实验中评估了DISS的疗效.
主要成果:
- GALE表达与严重和中性喘亚型相关.
- 在实验室中,DISS抑制了糖分分解,恢复了氧化还原平衡,并减轻了线粒体功能障碍.
- DISS减轻了呼吸道炎症,粘液过分分泌以及体内呼吸道重塑.
结论:
- GALE驱动的新陈代谢编程是喘进展的一个新机制.
- 通过向GALE,使糖解正常化,并减少氧化应激,DISS显示出治疗潜力.
- 通过解决代谢失调, DISS 提供了一种有前途的喘治疗策略.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
453
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
453
Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446
Antiasthma Drugs: β2-Adrenoceptor Agonists
374
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
374
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
382
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
382
Antiasthma Drugs: Methylxanthines
391
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
391


